首页EUFA3 • BVMF
add
Eurofarma Laboratorios SA
市场资讯
财务信息
损益表
收入
净收入
| (BRL) | 2025年9月info | 年同比变化 |
|---|---|---|
收入 | 32.09亿 | 14.03% |
经营支出 | 14.11亿 | -8.77% |
净收入 | 3.58亿 | 165.02% |
净利润率 | 11.15 | 132.29% |
每股收益 | — | — |
息税折旧摊销前利润 | 8.25亿 | 89.77% |
有效税率 | 10.45% | — |
资产负债表
总资产
负债总额
| (BRL) | 2025年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 12.87亿 | -40.20% |
总资产 | 178.31亿 | 3.99% |
负债总额 | 128.98亿 | 3.31% |
权益总额 | 49.32亿 | — |
发行在外的股份 | 9.89亿 | — |
市净率 | — | — |
资产回报率 | 10.11% | — |
资本回报率 | 12.00% | — |
现金流
现金净变动
| (BRL) | 2025年9月info | 年同比变化 |
|---|---|---|
净收入 | 3.58亿 | 165.02% |
来自运营的现金 | 5.02亿 | -4.09% |
投资现金 | -1.28亿 | 62.89% |
融资现金 | -5.77亿 | -404.59% |
现金净变动 | -2.13亿 | -163.15% |
自由现金流 | -2.31亿 | -15.34% |
简介
Eurofarma is a Brazilian multinational corporation engaged in biopharmaceutical manufacturing and is one of the largest medicine producers in Brazil and Latin America. Founded in 1972, Eurofarma offers generic, oncologic and veterinary medications. Within Brazil the company is responsible for about 2000 products, representing 66% of the total market.
Eurofarma has active operations in 20 countries, with factories in Brazil, Argentina, Bolivia, Chile, Colombia, Ecuador, Guatemala, Mexico, Mozambique, Paraguay, Peru, Uruguay and Venezuela. Wikipedia
成立时间
1972
员工数量
13,000
